Lipocine Inc. — Director's Dealing 2015

Jun 17, 2015

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Lipocine Inc. (LPCN)
CIK: 0001535955
Period of Report: 2015-06-16

Reporting Person: Ono Richard Dana (Director)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2015-06-16	Stock Option (Right to Buy)	$7.29	A	20000	Acquired	2025-06-15	Common Stock (20000)	Direct